NorthCrest Asset Manangement’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.91M Buy
42,753
+2,393
+6% +$496K 0.23% 107
2026
Q1
$9.04M Sell
40,360
-13,838
-26% -$3.45M 0.28% 97
2025
Q4
$13.3M Sell
54,198
-125
-0.2% -$32K 0.3% 91
2025
Q3
$15.4M Buy
54,323
+366
+0.7% +$100K 0.37% 82
2025
Q2
$13.9M Sell
53,957
-651
-1% -$155K 0.37% 79
2025
Q1
$12.2M Buy
54,608
+1,575
+3% +$368K 0.37% 83
2024
Q4
$12.1M Buy
53,033
+541
+1% +$130K 0.36% 82
2024
Q3
$12.8M Buy
52,492
+1,378
+3% +$308K 0.39% 81
2024
Q2
$9.78M Sell
51,114
-745
-1% -$151K 0.32% 89
2024
Q1
$10.3M Buy
51,859
+828
+2% +$152K 0.35% 87
2023
Q4
$8.78M Buy
51,031
+700
+1% +$108K 0.33% 91
2023
Q3
$7.44M Buy
50,331
+1,322
+3% +$239K 0.3% 103
2023
Q2
$10.7M Sell
49,009
-238
-0.5% -$53K 0.42% 79
2023
Q1
$10.8M Sell
49,247
-169
-0.3% -$36.7K 0.45% 75
2022
Q4
$10.3M Sell
49,416
-1,905
-4% -$419K 0.58% 59
2022
Q3
$11.2M Sell
51,321
-2,454
-5% -$559K 0.6% 60
2022
Q2
$11M Buy
53,775
+3,110
+6% +$662K 0.56% 65
2022
Q1
$12.3M Buy
50,665
+1,582
+3% +$383K 0.58% 64
2021
Q4
$12.8M Buy
+49,083
New +$12.7M 0.7% 44

Other funds holding RMD

NorthCrest Asset Manangement's RMD Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its ResMed (RMD) stake by 5.9% in Q2 2026, buying an estimated $496K and bringing the position to 42,753 shares worth $8.91M. The position accounts for 0.23% of the portfolio, ranked #107.

NorthCrest Asset Manangement first reported a position in RMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $15.4M in Q3 2025. 90 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • NorthCrest Asset Manangement held 42,753 shares of ResMed worth $8.91M as of Q2 2026.
  • NorthCrest Asset Manangement bought 2,393 ResMed shares in Q2 2026, an estimated $496K.
  • ResMed made up 0.23% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #107 holding.
  • NorthCrest Asset Manangement first reported a position in ResMed in Q4 2021 and has held it in 19 quarters since.
  • NorthCrest Asset Manangement's ResMed position peaked at $15.4M in Q3 2025.
  • 90 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.